These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32885989)

  • 41. 2019 White Paper On Recent Issues in Bioanalysis: FDA BMV Guidance, ICH M10 BMV Guideline and Regulatory Inputs (
    Booth B; Stevenson L; Pillutla R; Buonarati M; Beaver C; Fraier D; Garofolo F; Haidar S; Islam R; James C; Kadavil J; Kavetska O; Li F; Satterwhite C; Savoie N; Subramaniam S; Tampal N; Thway T; Woolf E; Blaye OL; Andisik M; Briscoe C; Cape S; Dasgupta A; Fischer S; Haidar S; Hayes R; Kamerud J; Lima Santos GM; Nehls C; Soo C; Vinter S; Whale E; Xu K; Cho SJ; Edmison A; Kassim S; Rocha TC; Welink J; Amur S; Bandukwala A; Cherry E; Hopper S; Ishii-Watabe A; Kirshner S; Maher K; Pedras-Vasconcelos J; Saito Y; Saunders TS; Skibeli V; Verthelyi D; Wang YM; Yan H
    Bioanalysis; 2019 Dec; 11(23):2099-2132. PubMed ID: 31833782
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative polymerase chain reaction in the bioanalytical laboratory and technical and scientific considerations for nonclinical and clinical assay characterization, validation and sample analysis.
    Laurén A; Braun M; Cazzin C; Colleti K; Cox C; Dietz L; Emrich T; Geddes K; Herr K; Iles T; Rogue A; Verlinden Y; Timmerman P
    Bioanalysis; 2022 Aug; 14(16):1085-1093. PubMed ID: 36125042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proposal for risk-based scientific approach on full and partial validation for general changes in bioanalytical method.
    Mochizuki A; Ieki K; Kamimori H; Nagao A; Nakai K; Nakayama A; Nanba E
    Bioanalysis; 2018 Apr; 10(8):577-586. PubMed ID: 29633860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pitfalls in bioanalytical work with a Japanese CRO or sponsor: from a project risk management perspective.
    Niwa M; Ohtsu Y; Katori N
    Bioanalysis; 2022 Dec; 14(24):1529-1532. PubMed ID: 36751138
    [No Abstract]   [Full Text] [Related]  

  • 45. Recommendations on the interpretation of the new European Medicines Agency Guideline on Bioanalytical Method Validation by Global CRO Council for Bioanalysis (GCC).
    Boterman M; Doig M; Breda M; Lowes S; Jersey J; Shoup R; Garofolo F; Dumont I; Martinez S; Needham S; Cruz Caturla M; Couerbe P; Guittard J; Maltas J; Lansing T; Bhatti M; Schiebl C; Struwe P; Sheldon C; Hayes R; Sangster T; Pattison C; Bouchard J; Goodwin L; Islam R; Segers R; Lin ZJ; Hillier J; Garofolo W; Zimmer D; Folguera L; Zimmermann T; Pawula M; Moussallie M; Teixeira Lde S; Rocha T; Tang D; Jardieu P; Truog J; Lin J; Lundberg R; Cox C; Breau A; Bigogno C; Schoutsen D; Dilger C; Bouhajib M; Levesque A; Gagnon-Carignan S; Nicholson R; Jenkins R; Lin MH; Karnik S; De Boer T; Houghton R; Green R; DeMaio W; Sable R; Smith K; Siethoff C; Cojocaru L; Allen M; Harter T; Fatmi S; Sayyarpour F; Malone M; Best S; Fang X
    Bioanalysis; 2012 Mar; 4(6):651-60. PubMed ID: 22452256
    [No Abstract]   [Full Text] [Related]  

  • 46. Biomarker context-of-use: how organizational design can impact the implementation of the appropriate biomarker assay strategy.
    Cowan KJ; Golob M; Goodman J; Laurén A; Andersen L; Decker P; Dejager L; Fjording MS; Groenen P; Jasnowski R; Justies N; Kimberg M; Kunz U; Lawrence J; Richter M; Sordé L; Trigt RV; Vermet L; Vitaliti A; Wright M; Timmerman P
    Bioanalysis; 2022 Jul; 14(13):911-917. PubMed ID: 35904153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Conference Report: 4th Japan Bioanalysis Forum Symposium: Japanese guidelines on bioanalytical method validation and latest discussion within the Japanese bioanalyst community.
    Nakayama A; Nakamura T
    Bioanalysis; 2014 Apr; 6(7):915-7. PubMed ID: 24806901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conference report: AAPS and US FDA Crystal City V meeting on Quantitative Bioanalytical Method Validation and Implementation: feedback from the EBF.
    Smeraglia J; McDougall S; Elsby K; Companjen A; White S; Golob M; Brudny-Kloeppel M; Amsterdam Pv; Timmerman P
    Bioanalysis; 2014 Mar; 6(6):729-32. PubMed ID: 24702107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validation of immunoassay for protein biomarkers: bioanalytical study plan implementation to support pre-clinical and clinical studies.
    Valentin MA; Ma S; Zhao A; Legay F; Avrameas A
    J Pharm Biomed Anal; 2011 Jul; 55(5):869-77. PubMed ID: 21530130
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The 20th International Reid Bioanalytical Forum.
    Houghton R
    Bioanalysis; 2014 Jan; 6(2):121-6. PubMed ID: 24423590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current Perspectives on Ligand-Binding Assay Practices in the Quantification of Circulating Therapeutic Proteins for Biosimilar Biological Product Development.
    Thway TM; Wang YM; Booth BP; Maxfield K; Huang SM; Zineh I
    AAPS J; 2019 Dec; 22(1):15. PubMed ID: 31858313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Recommendations on biomarker bioanalytical method validation by GCC.
    Hougton R; Gouty D; Allinson J; Green R; Losauro M; Lowes S; LeLacheur R; Garofolo F; Couerbe P; Bronner S; Struwe P; Schiebl C; Sangster T; Pattison C; Islam R; Garofolo W; Pawula M; Buonarati M; Hayes R; Cameron M; Nicholson R; Harman J; Wieling J; De Boer T; Reuschel S; Cojocaru L; Harter T; Malone M; Nowatzke W
    Bioanalysis; 2012 Oct; 4(20):2439-46. PubMed ID: 23157353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A survey of quality indicator use in the clinical laboratory.
    Preston LJ
    Clin Lab Sci; 2008; 21(1):25-32. PubMed ID: 18335858
    [TBL] [Abstract][Full Text] [Related]  

  • 54. European Bioanalysis Forum feedback on draft ICH M10 guideline on bioanalytical method validation during the Step 2b public consultation period.
    Timmerman P; Goodman J; Golob M; Haslberger T; Knutsson M; Nelson R; Verhaeghe T; White S
    Bioanalysis; 2020 Mar; 12(6s):1-11. PubMed ID: 32323555
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Method validation and measurement of biomarkers in nonclinical and clinical samples in drug development: a conference report.
    Lee JW; Weiner RS; Sailstad JM; Bowsher RR; Knuth DW; O'Brien PJ; Fourcroy JL; Dixit R; Pandite L; Pietrusko RG; Soares HD; Quarmby V; Vesterqvist OL; Potter DM; Witliff JL; Fritche HA; O'Leary T; Perlee L; Kadam S; Wagner JA
    Pharm Res; 2005 Apr; 22(4):499-511. PubMed ID: 15846456
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The European Bioanalysis Forum community's evaluation, interpretation and implementation of the European Medicines Agency guideline on Bioanalytical Method Validation.
    van Amsterdam P; Companjen A; Brudny-Kloeppel M; Golob M; Luedtke S; Timmerman P
    Bioanalysis; 2013 Mar; 5(6):645-59. PubMed ID: 23484783
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The ninth Japan Bioanalysis Forum symposium.
    Komaba J; Hosogi J; Igarashi H; Kamimori H; Nakai K; Nakamura T; Kawai Y; Sano Y; Yamaguchi T
    Bioanalysis; 2018 Sep; 10(18):1467-1471. PubMed ID: 30198754
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Workshop report: Crystal City V--quantitative bioanalytical method validation and implementation: the 2013 revised FDA guidance.
    Booth B; Arnold ME; DeSilva B; Amaravadi L; Dudal S; Fluhler E; Gorovits B; Haidar SH; Kadavil J; Lowes S; Nicholson R; Rock M; Skelly M; Stevenson L; Subramaniam S; Weiner R; Woolf E
    AAPS J; 2015 Mar; 17(2):277-88. PubMed ID: 25549614
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 9th GCC closed forum: CAPA in regulated bioanalysis; method robustness, biosimilars, preclinical method validation, endogenous biomarkers, whole blood stability, regulatory audit experiences and electronic laboratory notebooks.
    Hayes R; LeLacheur R; Dumont I; Couerbe P; Safavi A; Islam R; Pattison C; Cape S; Rocci M; Briscoe C; Cojocaru L; Groeber E; Silvestro L; Bravo J; Shoup R; Verville M; Zimmer J; Caturla MC; Khadang A; Bourdage J; Hughes N; Fatmi S; Di Donato L; Sheldon C; Keyhani A; Satterwhite C; Yu M; Fiscella M; Hulse J; Lin ZJ; Garofolo W; Savoie N; Xiao YQ; Kurylak K; Harris S; Saxena M; Buonarati M; Lévesque A; Boudreau N; Lin J; Khan MU; Ray G; Liu Y; Xu A; Soni G; Ward I; Kingsley C; Ritzén H; Tabler E; Nicholson B; Bennett P; van de Merbel N; Karnik S; Bouhajib M; Wieling J; Mulvana D; Ingelse B; Allen M; Malone M; Fang X
    Bioanalysis; 2016 Mar; 8(6):487-95. PubMed ID: 26916197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GCC Consolidated Feedback to ICH on the 2019 ICH M10 Bioanalytical Method Validation Draft Guideline.
    Nehls C; Buonarati M; Cape S; Islam R; Satterwhite C; Briscoe C; Hayes R; Dinan A; Sales K; Anderson S; Vance J; Lindsay J; Zimmer J; Couerbe P; Khadang A; Maasjo S; Bravo O; Lindley K; Moran L; Sangster T; Vija J; Stamatopoulos J; Lin J; Reuschel S; Underberg A; MacNeill R; Matassa L; Spytko A; Garofolo W; Savoie N; Rhyne P; Ambrosius J; Barra V; Dufield D; Luna M; Spriggs F; Fedorov E; Ritzén H; Fatmi S; Kane C; Bouhajib M; DiMarco C; Iordachescu A; Tudoroniu A; Farley E; Stouffer B; Tabler E; McCown S; Bower J; Harrison T; Karnik S; Brown M; Joyce P; DuBey I; Hoffpauir B; Boudreau N; Bergeron J; Wang H; Feng H; Zhou S; Wells E; Pirro J; Fang X; Shi J; Yang C
    Bioanalysis; 2019 Sep; 11(18s):1-228. PubMed ID: 31565956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.